"","Num","POD","SD","%","Genes","KE"
"GO:0001963","1","0.0075165942287035",NA,"8.33","559020","INCREASE DOPAMINERGIC ACTIVITY; DECREASED DOPAMINERGIC ACTIVITY"
"GO:0006633","1","0.0075165942287035",NA,"3.45","559020","SYNTHESIS DE NOVO FA; INCREASED DE NOVO FA SYNTHESIS; INCREASED DE NOVO FA SYNTHESIS"
"GO:0006636","1","0.0075165942287035",NA,"8.33","559020","UP REGULATION UNSATURATED FATTY ACID"
"GO:0006936","1","0.0075165942287035",NA,"1.82","559020","REDUCTION ABDOMINAL MUSCLE CONTRACTION; OVERACTIVATION MUSCLE CONTRACTION"
"GO:0016209","1","0.0075165942287035",NA,"9.09","559020","OXIDATION GLUTATHIONE"
"GO:0030728","1","0.0075165942287035",NA,"20","559020","DECREASE OVULATION"
"GO:0043542","1","0.0075165942287035",NA,"2.86","559020","INCREASED MIGRATION ENDOTHELIAL CELLS"
"GO:0050805","1","0.0075165942287035",NA,"5.88","559020","INCREASED NEURONAL SYNAPTIC INHIBITION"
"GO:0099536","1","0.0075165942287035",NA,"0.9","559020","DECREASED NEURONAL NETWORK FUNCTION IN ADULT BRAIN; DECREASED NEURONAL NETWORK FUNCTION IN ADULT BRAIN"
"GO:1903409","1","0.0075165942287035",NA,"4","559020","INCREASE ROS PRODUCTION; PRODUCTION REACTIVE OXYGEN SPECIES"
"GLUCOCORTICOID RECEPTOR PATHWAY","1","0.0075165942287035",NA,"4.17","559020","ACTIVATION GLUCOCORTICOID RECEPTOR"
"PROSTAGLANDIN SYNTHESIS AND REGULATION","1","0.0075165942287035",NA,"3.85","559020","REDUCTION PROSTAGLANDIN E2 CONCENTRATION; REDUCED PROSTAGLANDIN F2ALPHA CONCENTRATION PLASMA"
"G VEGF SIGNALING PATHWAY","1","0.0075165942287035",NA,"4.76","559020","REDUCED PRODUCTION VEGF"
"GO:0001516","2","0.0142763977191567","0.196998204142779","50","246227, 559020","REDUCED PROSTAGLANDIN F2ALPHA SYNTHESIS OVARY; DECREASED PROSTAGLANDIN F2ALPHA SYNTHESIS OVARY"
"GO:0004666","2","0.0142763977191567","0.196998204142779","50","246227, 559020","INHIBITION CYCLOOXYGENASE ACTIVITY; INHIBITION CYCLOOXYGENASE 1 ACTIVITY"
"GO:0006629","2","0.0202794349007025","0.304787589526948","0.97","559020, 30498","ALTERATION LIPID METABOLISM"
"GO:0007568","2","0.0288363395940663","0.412893102387979","2.33","559020, 394198","ACCELERATED AGING"
"GO:0007612","2","0.0288363395940663","0.412893102387979","8.33","559020, 394198","IMPAIRMENT LEARNING AND MEMORY"
"GO:0044703","2","0.0288363395940663","0.412893102387979","1.72","559020, 394198","N/A REPRODUCTIVE FAILURE"
"GO:0046983","3","0.0322227456837417","0.196620794406269","1.52","559020, 394198, 140814","DIMERIZATION AHR/ARNT; REDUCED DIMERIZATION ARNT/HIF1-ALPHA"
"GO:0000003","4","0.0367827805131585","0.123787910247287","1.97","559020, 394198, 30498, 140814","REDUCED REPRODUCTIVE SUCCESS; REPRODUCTIVE FAILURE"
"GO:0006305","1","0.0402353115241558",NA,"33.33","140814","ALKYLATION DNA; FORMATION PRO-MUTAGENIC DNA ADDUCTS"
"GO:0009790","1","0.0402353115241558",NA,"0.59","140814","DEFECT OF EMBRYOGENESIS"
"GO:0050673","1","0.0402353115241558",NA,"1.22","140814","INCREASE REGENERATIVE CELL PROLIFERATION TUBULAR EPITHELIAL CELLS; INCREASE REGENERATIVE CELL PROLIFERATION TERMINAL BRONCHIOLAR EPITHELIAL CELLS"
"LUNG FIBROSIS","1","0.0402353115241558",NA,"2.78","140814","LUNG FIBROSIS"
"GO:0045444","3","0.0435086484311976","0.260031153362517","7.32","559020, 140814, 567253","INCREASED ADIPOGENESIS"
"GO:0042446","1","0.0547130079632844",NA,"3.57","30498","INCREASE LUTEINIZING HORMONE LH; REPRESSED EXPRESSION OF STEROIDOGENIC ENZYMES"
"GO:0042698","1","0.0547130079632844",NA,"4.55","30498","IRREGULARITIES OVARIAN CYCLE"
"NRF2 PATHWAY","1","0.0547130079632844",NA,"2.5","30498","ACTIVATION NRF2"
"PEPTIDYL LYSINE MODIFICATION","1","0.0547130079632844",NA,"1.41","30498","N/A COVALENT BINDING TO PROTEIN POSSIBLY LYSINE RESIDUE"
"REGULATION OF WNT SIGNALING PATHWAY","1","0.0547130079632844",NA,"1.27","30498","INHIBITION WNT PATHWAY"
"LOCOMOTORY BEHAVIOR","1","0.0547130079632844",NA,"1.61","30498","REDUCED SWIMMING SPEED; REDUCED SWIMMING PERFORMANCE"
"GO:0005515","1","0.0577074094986752",NA,"2.13","30399","BINDING SH-/SELEN-PROTEINS; COVALENT BINDING PROTEIN"
"GO:0016055","1","0.0577074094986752",NA,"4.35","30399","ALTERATION WNT PATHWAY"
"GO:0001816","4","0.0727270155211615","0.246639470455618","3.33","405769, 559020, 30498, 140814","NON-NEURONAL PRODUCTION OF TNF EPITHELIAL IRRITATION; PRODUCTION OF NERVE GROWTH FACTOR  EPITHELIAL IRRITATION; NON-NEURONAL PRODUCTION OF IL-8/CXCL1 EPITHELIAL IRRITATION"
"POSITIVE REGULATION OF GENE EXPRESSION","4","0.0727270155211615","0.246639470455618","2.21","405769, 559020, 30498, 140814","ALTERED GENE EXPRESSION"
"HUMAN THYROID STIMULATING HORMONE TSH SIGNALING PATHWAY","2","0.0777991539491797","0.108105512861031","1.85","394198, 30498","DECREASED TRIIODOTHYRONINE T3 IN SERUM; INCREASE THYROID-STIMULATING HORMONE TSH; DECREASED THYROXINE T4 IN SERUM; INCREASED THYROID-STIMULATING HORMONE TSH"
"GO:0005488","9","0.0788663887571756","0.0732040955575122","0.84","246227, 405769, 559020, 394198, 30498, 140814, 567253, 317638, 30399","INCREASED BINDING OF CHEMICALS TO 2U SERUM"
"GO:0006954","4","0.0867237217081468","0.24640841015433","3.42","405769, 559020, 394198, 140814","INCREASE INFLAMMATION; INCREASE INFLAMMATION CORNEAL CELLS; INFILTRATION INFLAMMATORY CELLS; INCREASED INFLAMMATION; CHRONIC COUGH RESPIRATORY IRRITABILITY"
"GO:0072358","3","0.0885914680565767","0.396636093844544","2.7","405769, 559020, 30498","ALTERED CARDIOVASCULAR DEVELOPMENT/FUNCTION"
"BREAST CANCER PATHWAY","1","0.110626495974593",NA,"0.88","394198","N/A BREAST CANCER"
"ENDOMETRIAL CANCER","1","0.110626495974593",NA,"1.47","394198","INCREASE ENDOMETRIAL ADENOCARCINOMAS"
"NEUROINFLAMMATION","1","0.110626495974593",NA,"8.33","394198","N/A NEUROINFLAMMATION"
"OXIDATIVE STRESS","1","0.110626495974593",NA,"4.17","394198","PROPAGATION OXIDATIVE STRESS; N/A OXIDATIVE STRESS; INCREASE OXIDATIVE STRESS / ACTIVATION PMK-1 P38 MAPK; INCREASED OXIDATIVE STRESS; INCREASE OXIDATIVE STRESS / ACTIVATION PMK-1 P38 MAPK; INCREASE ENERGETIC DEMANDS AND THEREFORE METABOLIC STRESS; INCREASED ENERGETIC DEMANDS AND THEREFORE METABOLIC STRESS"
"SEROTONIN AND ANXIETY","1","0.110626495974593",NA,"8.33","394198","DECREASED ANXIETY"
"SIGNALING OF HEPATOCYTE GROWTH FACTOR RECEPTOR","1","0.110626495974593",NA,"2.94","394198","OCCURRENCE CYTOPLASMIC VACUOLIZATION HEPATOCYTE; OCCURRENCE BALLOONING DEGENERATION HEPATOCYTE"
"ABNORMAL CIRCULATING CHOLESTEROL CONCENTRATION","1","0.110626495974593",NA,"9.09","394198","DECREASED CHOLESTEROL; PERTURBATION OF CHOLESTEROL"
"ABNORMAL LIVER MORPHOLOGY","1","0.110626495974593",NA,"0.84","394198","INDUCTION LIVER “DYSFUNCTIONAL” CHANGES BY CGA 330050; INFLAMMATION LIVER; N/A LIVER FIBROSIS; INCREASE RBC CONGESTION IN LIVER; INCREASE LIVER AND SPLENIC HEMOSIDEROSIS; REDUCTION VITELLOGENIN SYNTHESIS IN LIVER; INCREASE VITELLOGENIN SYNTHESIS IN LIVER; FORMATION LIVER FIBROSIS; FORMATION LIVER TUMOR"
"ABNORMAL OVARIAN MORPHOLOGY","1","0.110626495974593",NA,"2.7","394198","PROMOTION OVARIAN GRANULAR CELL TUMORS; DECREASED OVARIAN E2; PROMOTION OVARIAN ADENOMAS"
"ABNORMALITY OF REPRODUCTIVE SYSTEM PHYSIOLOGY","1","0.110626495974593",NA,"0.97","394198","N/A IMPAIRMENT OF REPRODUCTIVE CAPACITY"
"ABNORMALITY OF THE ABDOMINAL ORGANS","1","0.110626495974593",NA,"0.59","394198","IMPAIRED DEVELOPMENT OF REPRODUCTIVE ORGANS"
"ABNORMALITY OF THE LIVER","1","0.110626495974593",NA,"0.13","394198","INCREASED INDUCTION OF UDPGT'S IN LIVER; INCREASED LIVER STEATOSIS; INCREASED LIVER STEATOSIS; N/A HEPATOTOXICITY HEPATOPATHY INCLUDING A CONSTELLATION OF OBSERVABLE EFFECTS; INDUCTION SUSTAINED HEPATOTOXICITY"
"ABNORMALITY OF THE OVARY","1","0.110626495974593",NA,"1.75","394198","REDUCED PROSTAGLANDINS OVARY"
"DECREASED BODY WEIGHT","1","0.110626495974593",NA,"0.44","394198","DECREASED BODY WEIGHT"
"LIPID ACCUMULATION IN HEPATOCYTES","1","0.110626495974593",NA,"3.12","394198","INCREASE PRENEOPLASTIC FOCI HEPATOCYTES"
"RESPONSE TO REACTIVE OXYGEN SPECIES","1","0.110626495974593",NA,"1.79","394198","INCREASED REACTIVE OXYGEN SPECIES"
"GO:0040011","2","0.112730790359502","0.831572739060289","0.88","405769, 559020","INCREASED LOCOMOTION; INCREASED MUSCULAR WAVES IN FOOT; DECREASED LOCOMOTION"
"GO:0048870","2","0.112730790359502","0.831572739060289","1","405769, 559020","INCREASED MOTILITY"
"GO:0001775","3","0.154972266890093","0.300414835050006","1.53","405769, 30498, 140814","ACTIVATION DENDRITIC CELLS"
"REGULATION OF CELL DEATH","5","0.162160055147634","0.130534479789632","1.87","405769, 394198, 30498, 140814, 567253","N/A CELL INJURY/DEATH"
"GO:0005102","2","0.260816872487509","0.573978595776977","0.96","405769, 140814","DECREASED TESTOSTERONE BINDING TO ANDROGEN RECEPTOR HYPOTHALAMUS"
"GO:0003714","1","0.272331766304941",NA,"5","567253","STABILIZATION PPAR ALPHA CO-REPRESSOR"
"GO:0015631","1","0.272331766304941",NA,"5.26","567253","BINDING TUBULIN"
"GO:0001820","1","1.69069005302284",NA,"33.33","405769","INCREASED SEROTONIN 5-HT"
"GO:0006898","1","1.69069005302284",NA,"2.63","405769","REDUCTION VITELLOGENIN ACCUMULATION INTO OOCYTES AND OOCYTE GROWTH/DEVELOPMENT; INCREASED LDL UPTAKE"
"GO:0009611","1","1.69069005302284",NA,"0.89","405769","ACCUMULATION DAMAGED MITOCHONDRIAL DNA"
"GO:0015908","1","1.69069005302284",NA,"4.55","405769","INCREASED FA INFLUX"
"GO:0016310","1","1.69069005302284",NA,"0.8","405769","ACTIVATION SP1"
"GO:0019904","1","1.69069005302284",NA,"0.81","405769","N/A INTERFERENCES WITH SH-/SELEN-PROTEINS"
"GO:0019932","1","1.69069005302284",NA,"1.64","405769","INCREASED SECOND MESSENGER PRODUCTION"
"GO:0042060","1","1.69069005302284",NA,"1.14","405769","FAILURE IN VASCULAR REPAIR MECHANISMS UNRESOLVED BLOOD LOSS HEMORRHAGE"
"GO:0042116","1","1.69069005302284",NA,"6.67","405769","INCREASED ACTIVATION AND RECRUITMENT OF HEPATIC MACROPHAGES KUPFFER CELLS"
"GO:0046903","1","1.69069005302284",NA,"0.43","405769","SUPPRESSION VLDL SECRETION; INCREASE MUCIN PRODUCTION; INCREASED SECRETION OF LOCAL GROWTH FACTORS"
"GO:0050663","1","1.69069005302284",NA,"3.33","405769","RELEASE CYTOKINE"
"JNK CASCADE","1","1.69069005302284",NA,"4.55","405769","ACTIVATION JNK"
"REGULATION OF PROTEOLYSIS","1","1.69069005302284",NA,"0.89","405769","IMPAIRED PROTEOSTASIS"
